2.1. Patients
T2D, hepatitis B-associated glomerulonephritis, PKUTH, autoimmune diseases, steroid diabetes, amyloidosis, renal injury, acute kidney injury, diabetes
URINARY TRACT INFECTIONS, TYPE 1 DIABETES, AUTOIMMUNE DISEASES, SYSTEMIC LUPUS ERYTHEMATOSUS, AMYLOIDOSIS, SJOGREN'S SYNDROME, RENAL TUMORS, DIABETES
We consecutively recorded 1,101 patients with T2D who underwent percutaneous renal biopsy from January 1, 2018, to December 31, 2019, at Peking University First Hospital (PKUFH) (289 patients) and from January 1, 2012, to December 31, 2020, at Peking University People's Hospital (PKUPH) (90 patients), Peking University Third Hospital (PKUTH) (259 patients), and Peking University International Hospital (PKUIH) (40 patients). Patients with type 1 diabetes, steroid diabetes and other special types of diabetes, acute kidney injury, autoimmune diseases such as systemic lupus erythematosus, Sjogren's syndrome, amyloidosis, hepatitis B-associated glomerulonephritis, renal tumors, drug-related renal injury, urinary tract infections, and unclear diagnoses or missing data were excluded (